|
Market Closed -
London S.E.
18:35:00 20/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 63.50 GBX | +4.10% |
|
+6.72% | -21.12% |
| 08-13 | EARNINGS AND TRADING: tinybuild sues Max Ent; Light Science loss grows | AN |
| 08-13 | Arecor Therapeutics plc Publishes Clinical Data for AT278 in Peer-Reviewed Journal | CI |
| Market Cap | 23.98M 32.71M 28M 26.13M 45.05M 3.13B 45.94M 310M 121M 1.57B 123M 120M 5.19B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 22.66M 30.91M 26.46M 24.69M 42.57M 2.96B 43.41M 293M 114M 1.48B 116M 114M 4.91B | EV / Sales 2026 * |
25.8x | EV / Sales 2027 * | 25.9x |
| Free-Float |
46.91% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arecor Therapeutics plc
| 1 day | +4.10% | ||
| 1 week | +6.72% | ||
| Current month | +4.10% | ||
| 3 months | -3.79% | ||
| 6 months | -12.41% | ||
| Current year | -21.12% |
| 1 week | 57 |  | 67 |
| 1 month | 55.27 | | 67 |
| Current year | 55.27 | | 95 |
| 1 year | 55.27 | | 100 |
| 3 years | 35.4 | | 199 |
| 5 years | 35.4 | | 472 |
| 10 years | 35.4 | | 472 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah Howell
CEO | Chief Executive Officer | 51 | 13/04/2021 |
David J. Ellam
DFI | Director of Finance/CFO | - | 18/11/2024 |
Jan Jezek
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2007 |
| Director | Title | Age | Since |
|---|---|---|---|
Sarah Howell
BRD | Director/Board Member | 51 | 13/04/2021 |
Mohammad Fazeli
BRD | Director/Board Member | 61 | 01/09/2017 |
Andrew Richards
CHM | Chairman | 66 | 13/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/4/25 A | Free | Executive/Senior Manager | 85,000 | 0.2251% | ||
| 6/4/25 A | Free | Chief Technology Officer | 85,000 | 0.2251% | ||
| 6/4/25 A | Free | Chief Executive Officer | 66,000 | 0.1748% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.10% | +6.72% | 0.00% | -66.58% | 31.34M | |
| +1.14% | +3.46% | +4.57% | +24.14% | 50.5B | |
| -1.36% | +3.15% | +479.46% | +614.84% | 46.01B | |
| -2.04% | +2.82% | +18.13% | +91.23% | 42.85B | |
| +2.72% | +5.93% | +33.12% | +19.66% | 41.03B | |
| 0.00% | -3.91% | +17.87% | +47.98% | 32.02B | |
| +0.72% | +2.62% | +32.57% | +145.37% | 16.98B | |
| -1.85% | -0.25% | - | - | 17.05B | |
| +3.06% | +4.63% | +7.40% | +35.00% | 14.3B | |
| +0.50% | +2.49% | +83.90% | +46.53% | 13.84B | |
| Average | +0.76% | +2.06% | +75.22% | +106.46% | 27.46B | |
| Weighted average by Cap. | +0.29% | +2.37% | +104.12% | +152.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 878K 1.2M 1.03M 957K 1.65M 115M 1.68M 11.36M 4.43M 57.47M 4.5M 4.4M 190M | 1.05M 1.43M 1.23M 1.14M 1.97M 137M 2.01M 13.58M 5.29M 68.69M 5.38M 5.26M 227M |
| Net income | - | - |
| Net Debt | -1.32M -1.8M -1.54M -1.44M -2.48M -172M -2.53M -17.06M -6.65M -86.34M -6.76M -6.61M -286M | 3.2M 4.37M 3.74M 3.49M 6.02M 418M 6.14M 41.41M 16.14M 210M 16.41M 16.05M 694M |
Employees
33
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | GBX 63.50 | +4.10% | 16,718 |
| 19/08/26 | GBX 61.00 | 0.00% | 18,116 |
| 18/08/26 | GBX 61.00 | 0.00% | 294,010 |
| 17/08/26 | GBX 61.00 | +2.52% | 332 |
| 14/08/26 | GBX 59.50 | 0.00% | 95,461 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.6350GBP
Average target price
2.755GBP
Spread / Average Target
+333.86%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AREC Stock
Select your edition
All financial news and data tailored to specific country editions
